Thrombophilia screening, including tests for protein C, protein S, antithrombin III levels, factor V Leiden mutation, prothrombin G20210A mutation, and antiphospholipid antibodies, was negative. This evidence concerns the gene F5 and Rare hereditary thrombophilia.